Healthcare is responsible for approximately 10% of U.S. greenhouse gas emissions and generates 6.2 million tons of regulated medical waste annually, at disposal costs of $0.25–$0.65 per pound. The proliferation of single-use disposable devices — driven by convenience, liability concerns, and infection control considerations — has been a major contributor to this burden. Yet the evidence on which approach (reusable or disposable) is actually superior across clinical, environmental, and economic dimensions is more nuanced than either automatic preference suggests. Our catalog includes both reusable and disposable products across all clinical categories, giving procurement teams the range to make evidence-based selections.
The Clinical Safety Argument for Reusables
Reusable devices that undergo proper decontamination (cleaning + disinfection/sterilization per AAMI/FDA standards) can achieve equivalent or greater safety than single-use alternatives. The key variable is the reprocessing program: OSHA-compliant healthcare laundry programs, validated sterilization cycles with biological indicator monitoring, and documented inspection/maintenance programs provide reliable safety assurance for appropriately designed reusable devices. Where reusables fail is in the "gray zone" — devices not designed for reprocessing but informally reprocessed anyway (often in cost-constrained settings) — which creates genuine safety risks from incomplete decontamination or structural failure.
Single-Use Device Reprocessing (SUDR): The Middle Path
FDA-regulated third-party reprocessing of labeled single-use devices (SUDs) has grown significantly as hospitals seek cost reduction. FDA-regulated SUDR companies (Stryker Sustainability Solutions, Medline ReNewal) collect used SUDs, reprocess them to FDA-validated cleaning and sterilization standards, relabel them with the reprocessor's FDA 510(k) clearance, and resell them at 30–50% below original manufacturer price. Clinical studies consistently demonstrate equivalent performance and safety of FDA-cleared reprocessed SUDs compared to original manufacturer devices. Hospitals participating in SUDR programs achieve annual savings of $1–$5 million at scale.
Environmental Lifecycle Analysis
Life cycle assessments (LCAs) consistently find that reusable devices have lower total environmental impact than disposable alternatives when reprocessing is efficient — but the comparison depends on the specific device, number of reprocessing cycles, and the energy source of the healthcare facility's sterilization operations. For some devices, break-even reuse cycles are as low as 3–5; for others (e.g., cotton surgical gowns requiring hot-water industrial laundering), lifecycle carbon footprint approaches single-use alternatives by cycle 50. The NHS's Green Surgery Report provides one of the most rigorous comparative analyses available, finding that reusable draping systems produce 35% lower carbon than single-use equivalents over a 100-case surgical program — available as a reference for UK and US sustainability teams. Healthcare facilities can find relevant diagnostic equipment in our catalog.
